Leila Rahbarnia

5.7k total citations
49 papers, 718 citations indexed

About

Leila Rahbarnia is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Leila Rahbarnia has authored 49 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 16 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Immunology. Recurrent topics in Leila Rahbarnia's work include Monoclonal and Polyclonal Antibodies Research (16 papers), Glycosylation and Glycoproteins Research (9 papers) and Antimicrobial Peptides and Activities (7 papers). Leila Rahbarnia is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (16 papers), Glycosylation and Glycoproteins Research (9 papers) and Antimicrobial Peptides and Activities (7 papers). Leila Rahbarnia collaborates with scholars based in Iran, Türkiye and France. Leila Rahbarnia's co-authors include Safar Farajnia, Bahman Akbari, Roghayyeh Baghban, Amir Ali Mafi, Younes Ghasemi, Masoumeh Rajabibazl, Reyhaneh Hoseinpoor, Hassan Dariushnejad, Asghar Tanomand and Mohammadreza Yousefi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Microbiology and Biotechnology and Drug Discovery Today.

In The Last Decade

Leila Rahbarnia

48 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leila Rahbarnia Iran 13 426 180 134 124 72 49 718
Mohammad Bagher Ghoshoon Iran 16 494 1.2× 117 0.7× 107 0.8× 157 1.3× 26 0.4× 41 740
Michael E. Hudson United States 8 555 1.3× 121 0.7× 120 0.9× 42 0.3× 42 0.6× 15 923
Krishan Kumar India 18 667 1.6× 136 0.8× 55 0.4× 84 0.7× 140 1.9× 53 1.3k
Mohammad M. Pourseif Iran 18 621 1.5× 149 0.8× 159 1.2× 48 0.4× 93 1.3× 35 1.1k
Hamid Sedighian Iran 16 400 0.9× 62 0.3× 121 0.9× 73 0.6× 46 0.6× 55 717
Chung‐Jr Huang United States 14 781 1.8× 173 1.0× 119 0.9× 181 1.5× 30 0.4× 18 1.0k
Zhifang Zhou China 19 701 1.6× 237 1.3× 337 2.5× 58 0.5× 88 1.2× 50 1.1k
Kuppamuthu Dharmalingam India 21 559 1.3× 98 0.5× 173 1.3× 54 0.4× 35 0.5× 78 1.2k
Shengshu Huang United States 17 1.1k 2.5× 238 1.3× 211 1.6× 119 1.0× 52 0.7× 20 1.3k

Countries citing papers authored by Leila Rahbarnia

Since Specialization
Citations

This map shows the geographic impact of Leila Rahbarnia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leila Rahbarnia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leila Rahbarnia more than expected).

Fields of papers citing papers by Leila Rahbarnia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leila Rahbarnia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leila Rahbarnia. The network helps show where Leila Rahbarnia may publish in the future.

Co-authorship network of co-authors of Leila Rahbarnia

This figure shows the co-authorship network connecting the top 25 collaborators of Leila Rahbarnia. A scholar is included among the top collaborators of Leila Rahbarnia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leila Rahbarnia. Leila Rahbarnia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farajnia, Safar, et al.. (2024). Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update. Molecular Biotechnology. 67(6). 2161–2184. 6 indexed citations
2.
Rahbarnia, Leila, et al.. (2024). Spotlight on HIV-derived TAT peptide as a molecular shuttle in drug delivery. Drug Discovery Today. 29(11). 104191–104191. 4 indexed citations
3.
4.
Farajnia, Safar, et al.. (2023). In silico Validation of Pseudomonas aeruginosa Exotoxin A Domain IInteraction with the Novel Human scFv Antibody. Infectious Disorders - Drug Targets. 23(5). e290323215113–e290323215113. 2 indexed citations
5.
Rahbarnia, Leila, et al.. (2023). The Synthetic Antimicrobial Peptide Derived From Melittin Displays Low Toxicity and Anti-infectious Properties. Probiotics and Antimicrobial Proteins. 16(2). 490–500. 10 indexed citations
6.
Farajnia, Safar, et al.. (2022). Design of a hybrid peptide derived from Melittin and CXCL14 –C17: A molecular dynamics simulation study. Biologia. 77(8). 2269–2280. 5 indexed citations
7.
Farajnia, Safar, et al.. (2021). Isolation and characterizations of a novel recombinant scFv antibody against exotoxin A of Pseudomonas aeruginosa. BMC Infectious Diseases. 21(1). 300–300. 8 indexed citations
8.
Rahbarnia, Leila, et al.. (2021). The prevalence of biofilm encoding genes in multidrug-resistant Acinetobacter baumannii isolates. Gene Reports. 23. 101094–101094. 6 indexed citations
9.
Akbarzadeh-Khiavi, Mostafa, Leila Rahbarnia, Azam Safary, et al.. (2021). Micronutrient therapy and effective immune response: a promising approach for management of COVID-19. Infection. 49(6). 1133–1147. 12 indexed citations
10.
Dehnad, Alireza, et al.. (2020). Detection of hemolysine genes in methicillin-resistant S. aureus isolates obtained from a healthy population in north-west of Iran. Gene Reports. 21. 100874–100874. 4 indexed citations
11.
Rahbarnia, Leila, et al.. (2019). Current trends in targeted therapy for drug-resistant infections. Applied Microbiology and Biotechnology. 103(20). 8301–8314. 12 indexed citations
12.
Baghban, Roghayyeh, et al.. (2019). CRISPR‐Cas system: Toward a more efficient technology for genome editing and beyond. Journal of Cellular Biochemistry. 120(10). 16379–16392. 10 indexed citations
13.
Dariushnejad, Hassan, et al.. (2017). DsbC chaperone mediated soluble expression of human TNF-α in E. coli. 30(1). 3 indexed citations
14.
Rahbarnia, Leila, et al.. (2016). Evolution of phage display technology: from discovery to application. Journal of drug targeting. 25(3). 216–224. 49 indexed citations
15.
Rahbarnia, Leila, Safar Farajnia, Hossein Babaei, et al.. (2016). Invert biopanning: A novel method for efficient and rapid isolation of scFvs by phage display technology. Biologicals. 44(6). 567–573. 17 indexed citations
16.
Rahbarnia, Leila, et al.. (2016). Development of a Novel Human Single Chain Antibody Against EGFRVIII Antigen by Phage Display Technology. Advanced Pharmaceutical Bulletin. 6(4). 563–571. 2 indexed citations
17.
Farajnia, Safar, et al.. (2015). Development and evaluation of a single domain antibody against human epidermal growth factor receptor (EGFR). Protein Expression and Purification. 120. 59–64. 10 indexed citations
18.
Farajnia, Safar, et al.. (2014). Cloning and Expression of the Variable Regions of Anti-EGFR Monoclonal Antibody in E. coli for Production of a Single Chain Antibody. Iranian Journal of Biotechnology. 12(2). 9–14. 2 indexed citations
19.
Farajnia, Safar, et al.. (2014). Development trends for generation of single-chain antibody fragments. Immunopharmacology and Immunotoxicology. 36(5). 297–308. 46 indexed citations
20.
Naderpour, Masoud, et al.. (2013). Tongue carcinoma: case series and demographic analysis. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammad Bagher Ghoshoon Breakdown of academic impact, for papers by Michael E. Hudson Breakdown of academic impact, for papers by Krishan Kumar Breakdown of academic impact, for papers by Mohammad M. Pourseif Breakdown of academic impact, for papers by Hamid Sedighian Breakdown of academic impact, for papers by Chung‐Jr Huang Breakdown of academic impact, for papers by Zhifang Zhou Breakdown of academic impact, for papers by Kuppamuthu Dharmalingam Breakdown of academic impact, for papers by Shengshu Huang
Rankless by CCL
2026